WuXi AppTec Co Ltd

CN

WUXIA

Health Care

4.29 ₽

Current price

Strong buy
4.29 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    3 / 240

  • Position in country

    163 / 7387

  • Return on Assets, %

    13.9

    -2.7

  • Net income margin, %

    20.2

    -6.7

  • EBITDA margin, %

    34.6

    5.6

  • Debt to Equity, %

    10.4

    15.1

  • Intangible assets and goodwill, %

    5

    4.7

  • Revenue CAGR 3Y, %

    34.6

    12.8

  • Total Equity change 1Y, %

    14.9

    -2.4

  • Revenue Y, % chg

    -2.7

    0

  • P/E

    13.2

    32.1

  • P/BV

    2.3

    2

  • P/S

    3.1

    4.1

  • EV/S

    2.8

    3.6

  • EV/EBITDA

    10

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    153.8

    48.9

  • Forward P/E

    11.6

    25.5

  • Dividend Yield, %

    2.7

    0.8

  • Forward Dividend Yield, %

    3.2

    0.2

  • Expected dividend per share

    0.1

    0

  • Payout Ratio, %

    30

    10.1

  • Dividend Ex Date

    2023-06-05

Get an analytical review of this company

Competitors

Ranks

  • WuXi AppTec Co Ltd

    00%

  • Pharmaron Beijing Co Ltd

    00%

  • WuXi XDC Cayman Inc

    00%

  • Hangzhou Bio-Sincerity Pharma-Tech Co Ltd

    00%

  • Joinn Laboratories China Co Ltd

    00%

  • WuXi Biologics (Cayman) Inc

    00%

  • Genscript Biotech Corp

    00%

  • Shanghai Runda Medical Technology Co Ltd

    00%

  • Hangzhou Tigermed Consulting Co Ltd

    00%

  • MGI Tech Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    16823.1

  • Ticker

    WUXAY.PK

  • ISIN

    US98260P1030

  • IPO date

    2018-05-08

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-18

  • Date fact. publication of reports

    2023-12-31

Company Description

WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.